Educational content from trusted sources. Not a substitute for advice from your doctor or pharmacist.

Medication guide

Tapentadol Side Effects and Boxed Warnings Explained

Tapentadol side effects explained: how often nausea, dizziness and constipation occur, what the FDA boxed warnings mean, and when to get help.

Information gathered from trusted sources

Updated November 18, 2026

Illustration of a lighthouse on a teal headland shining a soft beam over calm water while a person watches from the shore, representing watching for tapentadol side effects and warning signs

Key facts

  • The most common tapentadol side effects in FDA-reviewed trials were nausea, dizziness, vomiting, sleepiness and constipation. Headache, itching, dry mouth and sweating are also common. See our tapentadol overview for how it works.
  • Tapentadol (Nucynta, Nucynta ER) carries FDA boxed warnings for addiction, life-threatening slowed breathing, accidental swallowing by children, newborn withdrawal and dangerous mixing with benzodiazepines or other sedatives.
  • Less common but serious risks include serotonin syndrome, seizures, low adrenal function, severe low blood pressure and sleep-related breathing problems.
  • In pooled long-term trials, stomach and bowel side effects were less frequent with extended-release tapentadol than with oxycodone, but still common.
  • Slow or shallow breathing, extreme sleepiness or being hard to wake is an emergency. Call 911 and give naloxone if you have it.

If you have just been prescribed tapentadol, or you are caring for someone who takes it, knowing the likely tapentadol side effects ahead of time makes the first weeks easier and safer. Most people notice something, often queasiness or light-headedness, and many effects ease as the body adjusts. A few are serious and need fast action.

This guide walks through what the FDA labels report, how often the common effects happen, what each boxed warning means in plain English, and when to call your prescriber or 911. For background on what the medicine is and how it works, start with our tapentadol (Nucynta) guide.

Common tapentadol side effects and how often they happen

The numbers below come straight from the FDA prescribing information. For immediate-release Nucynta tablets, the FDA label pools short-term trials of more than 2,000 people taking tapentadol. For Nucynta ER, the extended-release label reports trials in chronic low back pain, osteoarthritis and diabetic nerve pain. Placebo rates are shown so you can see how much is caused by the drug itself.

Side effectNucynta (immediate-release)Nucynta ER (back pain and arthritis trials)Placebo (IR / ER trials)
Nausea30%21%13% / 7%
Dizziness24%17%8% / 6%
Vomiting18%Under 10%4% / not in top list
Sleepiness (somnolence)15%12%3% / 4%
Constipation8%17%3% / 7%
HeadacheUnder 10%15%Not in top list / 13%
Itching5%Under 10%1% / not in top list

Nausea and dizziness are the effects most likely to make people stop: in the immediate-release trials, about 2.6% stopped because of dizziness and 2.3% because of nausea. Constipation shows up more with the extended-release form, which is taken around the clock for chronic pain.

MedlinePlus also lists headache, heartburn, stomach pain, dry mouth, tiredness, anxiety, irritability, trouble sleeping, unusual dreams and a sudden feeling of warmth. Mention any of these to your prescriber if they are severe or do not go away.

Is tapentadol easier on the stomach than other opioids?

Somewhat, according to the trial data. A 2019 safety review in the Journal of Pain Research describes a pooled analysis of four large trials in chronic back and arthritis pain. Stomach and bowel side effects were reported by 26.6% of people on placebo, 47.3% on extended-release tapentadol and 65.4% on controlled-release oxycodone. Moderate or severe constipation affected 2.4%, 8.6% and 18.5%, respectively.

That is a meaningful difference, but nearly half of the people taking tapentadol still had a stomach or bowel side effect. If you are weighing it against another opioid, our tapentadol vs tramadol comparison covers how the two differ in side effects and risks.

Practical ways to cope with common side effects

  • Nausea: it is usually worst in the first days. Ask your prescriber or pharmacist whether taking the dose with food or a short-term anti-nausea medicine makes sense for you.
  • Constipation: fluids, fiber and movement help, but opioid constipation often needs a laxative plan. Cleveland Clinic advises calling your care team if you have not had a bowel movement in three days.
  • Dizziness and sleepiness: stand up slowly, and do not drive or use machinery until you know how tapentadol affects you. The FDA label warns about impaired driving.
  • Dry mouth: sip water, chew sugar-free gum and keep up with dental care.

Never change your dose or stop suddenly to avoid a side effect. Talk to your prescriber first.

Tapentadol boxed warnings explained

A boxed warning is the strongest safety warning the FDA puts on a prescription label. Tapentadol shares these with other opioid pain medicines.

Boxed warningWhat it means in plain language
Addiction, abuse and misuseTapentadol can lead to addiction even when taken as prescribed. Your prescriber should check your risk before and during treatment.
Life-threatening respiratory depressionBreathing can slow to a dangerous level. The risk is highest in the first 24 to 72 hours and after any dose increase.
Accidental ingestionEven one dose swallowed by a child, or by an adult it was not prescribed for, can be fatal.
Neonatal opioid withdrawal syndromeLong-term use during pregnancy can cause withdrawal in the newborn, which can be life-threatening without treatment.
Benzodiazepines and other CNS depressantsCombining tapentadol with sedatives, sleeping pills, alcohol or other opioids can cause deep sedation, slowed breathing, coma and death.
Opioid Analgesic REMSA federal safety program requiring education for prescribers and a medication guide for patients.

Nucynta ER tablets carry an extra caution: they must be swallowed whole. Crushing, chewing or dissolving them can release the full dose at once and cause a fatal overdose, according to the Nucynta ER label.

What changed in 2025

On July 31, 2025, the FDA required all opioid pain medicine labels to be updated with data on long-term use. Two large FDA-required studies found that about 1% to 6% of people on long-term opioid therapy newly developed addiction over 12 months. The updates also stress that higher doses raise overdose risk, add gabapentinoids (such as gabapentin and pregabalin) to the list of risky combinations, add opioid-induced esophageal dysfunction as a stomach and swallowing warning, and warn against stopping suddenly or tapering too fast because of withdrawal, uncontrolled pain and suicide risk.

Serious side effects to know about

These are less common, but you should be able to recognize them. They are listed in the Warnings and Precautions section of the 2023 Nucynta prescribing information.

Serotonin syndrome

Tapentadol raises norepinephrine, and combined with antidepressants (SSRIs, SNRIs, tricyclics), triptans for migraine or other serotonin-boosting drugs it can contribute to serotonin syndrome. The label says this can happen even at recommended doses. Signs include agitation, hallucinations, fever, heavy sweating, a fast heartbeat, shivering, muscle stiffness or twitching, loss of coordination and diarrhea. Tapentadol must not be used with MAO inhibitors or within 14 days of stopping one.

Seizures

Tapentadol has not been studied in people with seizure disorders and may make seizures more likely. Tell your prescriber about any history of epilepsy or seizures.

Low adrenal function

Adrenal insufficiency has been reported with opioids, more often after more than a month of use. Watch for nausea, vomiting, loss of appetite, unusual tiredness or weakness, and dizziness.

Low blood pressure and fainting

Tapentadol can cause blood pressure to drop, especially when you stand up, and fainting can follow.

Sleep apnea and increased pain sensitivity

Opioids can cause central sleep apnea and low oxygen during sleep, and the risk rises with dose. They can also, rarely, make pain worse rather than better. This is called opioid-induced hyperalgesia. If your pain spreads, gets worse or new pain appears while you are taking tapentadol, tell your prescriber rather than taking extra doses.

Hormone and other effects

MedlinePlus lists erection problems, irregular periods and lower sex drive as possible effects of long-term use, along with allergic reactions such as hives or swelling of the face, lips, tongue or throat. The Mayo Clinic list also includes vision changes. Liver or kidney problems can raise the risk of side effects, so share your full health history.

When to get emergency help. Call 911 right away if someone taking tapentadol has slow, shallow or noisy breathing, cannot be woken or responds poorly, has blue or gray lips or fingernails, has tiny pupils, has a seizure, or has swelling of the face or throat. If you have naloxone, give it. The CDC says naloxone can restore breathing within 2 to 3 minutes and will not harm someone who is not having an opioid overdose. Stay with the person until help arrives. For questions about a possible overdose or a child who swallowed a pill, call Poison Help at 1-800-222-1222. If you are having thoughts of suicide, call or text 988.

Withdrawal is a side effect too

After regular use, the body becomes physically dependent on tapentadol. Stopping suddenly or cutting the dose too fast can cause withdrawal. The Nucynta ER label lists restlessness, watery eyes, runny nose, yawning, sweating, chills, muscle aches and widened pupils, as well as irritability, anxiety, trouble sleeping, nausea, vomiting, diarrhea and a faster heart rate. Pain can also return. Any reduction should be planned with your prescriber, who will set the pace for you.

Questions to ask your prescriber

  • Which side effects should I expect in the first week, and which ones mean I should call you?
  • Should I start a laxative now, and which one?
  • Could any of my other medicines, including antidepressants, migraine medicines, gabapentin or sleep aids, interact with tapentadol?
  • Should I keep naloxone at home, and can you prescribe it or tell me where to get it?
  • How long do you expect me to take tapentadol, and how will we decide when to stop?

You can report a suspected side effect to FDA MedWatch at 1-800-FDA-1088.

Frequently asked questions

What are the most common tapentadol side effects?

In FDA-reviewed trials, the most common were nausea, dizziness, vomiting, sleepiness and constipation. Headache, itching, dry mouth and sweating were also reported. Many of these ease after the first days or weeks.

Does tapentadol cause less constipation than other opioids?

In pooled long-term trials, moderate or severe constipation was less common with extended-release tapentadol than with controlled-release oxycodone (8.6% vs 18.5%). Constipation is still common, so ask your prescriber about a bowel plan from the start.

Can tapentadol cause serotonin syndrome?

Yes. The FDA label warns that serotonin syndrome can occur, mainly when tapentadol is combined with antidepressants, triptans or other serotonin-boosting drugs. Seek urgent care for agitation, fever, sweating, a fast heartbeat, shivering or muscle twitching.

How long do tapentadol side effects last?

Nausea, dizziness and sleepiness are often worst at the start and after dose changes, and they usually improve as your body adjusts. Constipation often continues as long as you take the medicine. Tell your prescriber about any side effect that does not get better.

What should I do if someone taking tapentadol will not wake up?

Treat it as an emergency. Call 911, give naloxone if you have it, and stay with the person. Try to keep them breathing and on their side until help arrives.

Related guides

Sources

  1. US Food and Drug Administration. NUCYNTA (tapentadol) tablets: Full prescribing information, revised October 2019.
  2. US Food and Drug Administration. NUCYNTA ER (tapentadol) extended-release tablets: Full prescribing information, revised October 2019.
  3. US Food and Drug Administration. NUCYNTA (tapentadol) oral solution: Full prescribing information, revised July 2023.
  4. US Food and Drug Administration. FDA is requiring opioid pain medicine manufacturers to update prescribing information regarding long-term use, July 31, 2025.
  5. MedlinePlus, US National Library of Medicine. Tapentadol.
  6. Polati E, Canonico PL, Schweiger V, Collino M. Tapentadol: an overview of the safety profile. J Pain Res. 2019;12:1569-1576.
  7. Centers for Disease Control and Prevention. 5 Things to Know About Naloxone.
  8. Mayo Clinic. Tapentadol (oral route): Side effects.
  9. Cleveland Clinic. Tapentadol tablets.

This guide is for education only

It does not replace advice from your doctor or pharmacist. Never start, stop, or change a medicine on your own. In an emergency call 911; for possible overdose or poisoning call Poison Help at 1-800-222-1222.

Information gathered from trusted sources, including FDA prescribing information, DailyMed, NIH and peer-reviewed research. Sources are cited throughout this guide. Read our editorial policy.